Cross-Sector entity
Of the tracked stories, 7 of 7 also mention Eucalyptus, the most common co-covered peer. Across a 114-day span, the pace is roughly 0.4 stories per week. The busiest single day carried 4. The clearest coverage concentration is acquisition: 3 of 7 stories, with the rest divided among 2 other categories.
7 verified stories tracked
Last mentioned: Jun 17, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 14 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 7 of 7 also mention Eucalyptus, the most common co-covered peer. Across a 114-day span, the pace is roughly 0.4 stories per week. The busiest single day carried 4. The clearest coverage concentration is acquisition: 3 of 7 stories, with the rest divided among 2 other categories. 43% of these stories carry negative sentiment. The tracked stories average 2.9 original sources each. This profile follows 7 Cross-Sector stories mentioning Tim Doyle across the period from February 24, 2026 to June 17, 2026.
Computed from the 7 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Tim Doyle. Shared-story counts are live from our verified record — not editorial picks.
Parliamentary Inquiry Hearing
Australian Investment Council CEO Navleen Prasad warns tax changes could erase startup ecosystem; Tim Doyle advocates for employee equity exemption.
Global Market Reaction
Industry analysts note the deal as a major consolidation in the GLP-1 and telehealth sectors.
Employee Windfall Reports
Detailed reports emerge regarding the 100+ employees reaching millionaire status in Sydney.
Payout Details Emerge
Former CCO Joe Harris confirms a payout exceeding $1 million, highlighting the impact on staff wealth.
Executive Payouts Confirmed
Former CCO Joe Harris confirms a $1M+ payout in an interview with the Australian Financial Review.
Acquisition Announced
Hims & Hers officially announces the $1.6 billion buyout of Sydney-based Eucalyptus.
GLP-1 Surge
Juniper and Pilot brands see explosive growth driven by demand for weight-loss medications.
Eucalyptus Founded
Tim Doyle launches the company, inspired by the Hims & Hers telehealth model in the US.
Startup founders and investors clash over the impact of proposed CGT reforms at a parliamentary inquiry. While venture capital body warns iconic companies would not exist, Tim Doyle believes founders will still chase moonshots but calls for protecting employee equity from higher tax.
The proposed CGT overhaul faces legal scrutiny as testimony reveals stark consequences for venture capital and employee equity. Key legal considerations include the transition to an inflation-indexed model and potential carve-outs for early-stage equity.
Finance professionals face a potential re-rating of Australian venture capital as proposed CGT reforms threaten after-tax returns. Testimony at a parliamentary inquiry highlighted that key unicorns might not exist under new rules, while a recent $1B exit underscores what’s at stake.
Source: Tess Ikonomou (au) · Tess Ikonomou AAP
US telehealth giant Hims & Hers has completed a $1.6 billion acquisition of Australian startup Eucalyptus, marking a massive expansion into the Asia-Pacific market. The deal has created over 100 millionaires among Eucalyptus's Sydney-based workforce through a $300 million employee share pool.
US telehealth giant Hims & Hers has acquired Sydney-based startup Eucalyptus in a landmark $1.6 billion deal. The acquisition, fueled by a $637 million revenue run-rate and the global GLP-1 weight loss boom, has created over 100 overnight millionaires among the Australian firm's staff.
US telehealth leader Hims & Hers has finalized a $1.6 billion acquisition of Australian digital health startup Eucalyptus, marking a major expansion into the Asia-Pacific market. The deal, driven by the explosive growth of GLP-1 weight-loss treatments, creates over 100 employee millionaires and solidifies Hims & Hers' position as a global powerhouse in direct-to-consumer healthcare.
US telehealth leader Hims & Hers has acquired Australian startup Eucalyptus in a $1.6 billion deal, triggering a massive wealth event for over 100 employees through its share option plan. The acquisition highlights the explosive growth of the GLP-1 and telehealth markets while setting a new benchmark for employee equity outcomes in the Australian tech ecosystem.
Source: Internewscast (us) · Caitlin Powell (gb)
